Form 4: SPX Technologies Executive John William Swann III Reports Stock and Option Awards

Sentiment:

SEC Form 4 Filing


John William Swann III, an executive at SPX Technologies, reported the acquisition of restricted stock units and stock options, as well as adjustments to his holdings in the company's common stock and 401(k) plan.

Summary

  • On February 28, 2024, John William Swann III, a President at SPX Technologies, reported changes in his beneficial ownership of the company's securities.
  • He acquired 5,524 shares of common stock through the grant of restricted stock units under the SPX 2019 Stock Compensation Plan.
  • He also received an option to purchase 4,215 shares of common stock at an exercise price of $116.40, which vests in three equal installments beginning on February 28, 2025.
  • Swann's total direct holdings of common stock after the reported transactions amount to 90,644 shares, which includes unvested restricted stock units.
  • He also holds 4,047 shares of common stock indirectly through a 401(k) plan.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the document simply reports stock and option awards, which are a common part of executive compensation. There is no indication of positive or negative sentiment.

Positives

  • The grant of restricted stock units and stock options aligns the executive's interests with those of the shareholders.
  • The vesting schedules of the stock options incentivize long-term performance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's confidence in the company's prospects.

Stakeholder Impact

  • The stock and option awards could potentially dilute existing shareholders' equity.
  • The awards incentivize the executive to improve company performance, which could benefit shareholders.

Key Dates

DateDescription
02/22/2021Date of employee stock option grant with an exercise price of $32.69, vesting in three equal installments beginning on this date.
02/21/2022Date of employee stock option grant with an exercise price of $36.51, vesting in three equal installments beginning on this date.
02/20/2023Date of employee stock option grant with an exercise price of $50.09, vesting in three equal installments beginning on this date.
02/28/2024Date of transaction: Grant of restricted stock units and stock options.
03/01/2024Date of employee stock option grant with an exercise price of $58.34, vesting in three equal installments beginning on this date.
02/28/2025First vesting date for the stock options granted on February 28, 2024.
03/01/2025Date of employee stock option grant with an exercise price of $48.97, vesting in three equal installments beginning on this date.
03/01/2026Date of employee stock option grant with an exercise price of $71.93, vesting in three equal installments beginning on this date.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.